Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 9 lis 2017 · During the study period from 5 to 20 years, the absolute risk of distant recurrence among patients with T1N0 breast cancer was 10% for low-grade disease, 13% for moderate-grade disease,...

  2. 25 sty 2022 · Historically, only a minority of patients with metastatic breast cancer survived beyond 10 years . In recent times, expected survival has greatly improved, with data from the Surveillance, Epidemiology and End Results (SEER) suggest 5-year survival in the setting of metastatic disease to be 27% .

  3. There were 949 patients diagnosed between 2005 and 2016 treated with NAC followed by surgery ± locoregional radiotherapy (LRRT). Outcomes were 7-year locoregional relapse-free survival (LRRFS), breast cancer-specific survival (BCSS), and overall survival (OS).

  4. 15 lut 2023 · Breast cancer–specific survival at 10 years was 97.4% (95% CI, 96.0 to 98.8) among patients assigned to no radiotherapy and 97.9% (95% CI, 96.5 to 99.2) among patients assigned to...

  5. 8 lis 2001 · Radiotherapy prevents local recurrence of breast cancer after breast-conserving surgery. We evaluated the effect of a supplementary dose of radiation to the tumor bed on the rates of...

  6. 17 lip 2021 · With improved early diagnosis and advanced treatment approaches, current survival is high with 5- and 15-year relative survival rates of 91% and 80% (Breast Cancer Facts and Figures 2019–2020), respectively.

  7. 22 lis 2022 · Even in the age group with the highest recurrence rate, 10-year locoregional recurrence remains low at 4.2% 25.